We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

How to Evaluate a Sinonasal Mass: Key Recommendations from a Multidisciplinary Consensus

MedXY Editorial Team•Jul 20, 2026•news
biopsyimagingnasal masssinonasal

Introduction and Context

Nasal cavity and paranasal sinus masses are common clinical findings, ranging from benign inflammatory polyps to rare but aggressive malignancies. Mistakes in the initial evaluation—missed imaging, inappropriate or blind biopsy, or inadequate pathology workup—can delay diagnosis, cause complications, or misdirect treatment. To address these issues, a multidisciplinary expert panel published a consensus statement in JAMA Otolaryngology—Head & Neck Surgery (London et al., 2026) with 23 proposed recommendations for the evaluation and workup of sinonasal masses. This article synthesizes the core guidance, highlights what changed or was emphasized compared with prior practice patterns, and translates the recommendations into actionable steps for clinicians.

Why this consensus now? Advances in imaging, endoscopic techniques, and tumor molecular diagnostics, plus recognition of frequent diagnostic pitfalls, made an updated, multidisciplinary approach necessary. The consensus was developed following a systematic literature review (1990–2025) and a modified Delphi process involving otolaryngologists (general, rhinology, head and neck), neurosurgery, and medical oncology from North America and the UK.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Imaging-Guided Classification and Diagnostic Pathways for Appendiceal Abscesses: Practical Takeaways from the 2025 Italian ConsensusA clear, imaging-centered framework for diagnosing and stratifying appendiceal abscesses—introducing anatomotopographic localization, the Jeffrey radiological grading, and pathway-based imaging recommendations to harmonize practice.Sep 15, 2026When to Image: Expert Consensus on Staging and Surveillance Imaging for Cutaneous Squamous Cell CarcinomaA multidisciplinary Delphi panel offers practical, consensus-based recommendations to standardize when and how to use staging and surveillance imaging for localized cutaneous squamous cell carcinoma (CSCC).Jul 12, 2026Advancing Otologic Imaging: Machine Learning-Derived Synthetic CT from Temporal Bone MRIA machine learning algorithm can generate synthetic CT images from temporal bone MRI, enabling visualization of bone and soft tissue simultaneously without radiation, useful for otologic surgical planning and localization.Jun 25, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Five-Year Safety of Avoiding Biopsy After Negative MRI in Prostate Cancer Pathways
Long-term data show RAPID MRI-directed pathway safely avoids unnecessary biopsies while maintaining low rates of clinically significant prostate cancer.
Dec 17, 2025
Routine Whole‑Body Imaging Did Not Improve Early Survival in High‑Risk Melanoma: Interim TRIM Trial AnalysisInterim results from the multicentre phase 3 TRIM trial show no survival benefit from adding scheduled whole‑body CT or FDG‑PET‑CT to physical‑examination follow‑up after radical surgery for stage IIB–C and III cutaneous melanoma at median Nov 5, 2025
AI-RAPNO: Translating Artificial Intelligence into Reliable Response Assessment for Pediatric Neuro-OncologyAI-RAPNO synthesizes current AI developments for pediatric brain tumour imaging and provides practical recommendations to improve trustworthiness, generalisability, and clinical implementation of AI-driven response assessment using the RAPNNov 4, 2025